Bioharvest Sciences Inc (BHST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,130 | -9,827 | -8,074 | -5,030 | -6,809 |
| Depreciation Amortization | 136 | 389 | 251 | 135 | 60 |
| Accounts receivable | -130 | -266 | -316 | -224 | -114 |
| Other Working Capital | -398 | -96 | -19 | -349 | 214 |
| Other Operating Activity | 19 | 3,006 | 3,650 | 2,389 | 5,446 |
| Operating Cash Flow | $-2,503 | $-6,794 | $-4,508 | $-3,079 | $-1,203 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -391 | -1,640 | -1,286 | -780 | -257 |
| Investing Cash Flow | $-391 | $-1,640 | $-1,286 | $-780 | $-257 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 146 | 11,104 | 11,054 | 5,719 | 5,701 |
| Other Financing Activity | -103 | -332 | -229 | -137 | -69 |
| Financing Cash Flow | $43 | $10,772 | $10,825 | $5,582 | $5,632 |
| Exchange Rate Effect | N/A | -4 | -2 | -1 | 1 |
| Beginning Cash Position | 4,117 | 1,783 | 1,783 | 1,783 | 1,783 |
| End Cash Position | 1,266 | 4,117 | 6,812 | 3,505 | 5,956 |
| Net Cash Flow | $-2,851 | $2,334 | $5,029 | $1,722 | $4,172 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,503 | -6,794 | -4,508 | -3,079 | -1,203 |
| Capital Expenditure | -391 | -1,640 | -1,286 | -780 | -257 |
| Free Cash Flow | -2,894 | -8,434 | -5,794 | -3,859 | -1,460 |